Compared to non-metastatic patients, the GREM2 and CTSS genes exhibited significantly higher expression levels, while TINAGL1, ACKR1, and HLA-DRB1 showed a tendency to increase in metastatic soft tissue sarcoma (SS); however, these differences were not statistically significant. This evidence concerns the gene TINAGL1 and soft tissue sarcoma.